Admetsys' FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
Posted:
Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
A wave of British scientific breakthroughs is poised to transform how prostate cancer is found and treated.
Prostate cancer is the most common cancer in men across the UK, and the second most common cause of cancer deaths after lung cancer. …
Free live virtual Learna Open Day for healthcare professionals considering postgraduate study. See how online study works, view the platform live, and submit questions. Wed 11 Feb, 13:00 GMT.
Read more and register here.
Attendees
Sponsors and Exhibitors
Contact us